Potential New HIV Therapy Tops SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. Switchable CAR T-Cell System Shows Promise in Pancreatic Cancer Treatment

The switchable CAR T system allows for complete control of the cancer-killing cells, which could improve the treatment’s safety. Read more.

4. The Growth of mHealth in Specialty Pharmacy

Mobile technology has helped to facilitate communication between pharmacists, patients, and their caregivers. Read more.

3. Amgen Will Cut Repatha List Price by 60%

Amgen will make evolocumab (Repatha) available at a list price of $5850, a 60% reduction from its annual list price of $14,100. Read more.

2. FDA Approves New Influenza Treatment

The approval marks the first new antiviral flu treatment with a novel mechanism of action backed by the agency in nearly 20 years. Read more.

1. NDA Submitted to FDA for Single-Tablet, 2-Drug HIV Treatment Regimen

Dolutegravir plus lamivudine showed non-inferiority to a 3-drug, first-line regimen in treating HIV infection. Read more.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.